"Nucleosides" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed)
| Descriptor ID |
D009705
|
| MeSH Number(s) |
D09.408.595 D13.570
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Nucleosides".
Below are MeSH descriptors whose meaning is more specific than "Nucleosides".
This graph shows the total number of publications written about "Nucleosides" by people in this website by year, and whether "Nucleosides" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 2002 | 1 | 0 | 1 |
| 2003 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Nucleosides" by people in Profiles.
-
Hou W, Trieu C, Du Y, Wang C, Syn WK. Profile of drug resistance mutations in nucleos(t)ide analogue-experienced chronic hepatitis B patients in Tianjin, China. Int J Antimicrob Agents. 2018 Nov; 52(5):735-736.
-
Rao KV, Santarsiero BD, Mesecar AD, Schinazi RF, Tekwani BL, Hamann MT. New manzamine alkaloids with activity against infectious and tropical parasitic diseases from an Indonesian sponge. J Nat Prod. 2003 Jun; 66(6):823-8.
-
Davis WC, Venzie JL, Willis B, Coffee RL, Arya DP, Marcus RK. Particle beam glow discharge mass spectrometry: spectral characteristics of nucleobases. Rapid Commun Mass Spectrom. 2003; 17(15):1749-58.
-
Shukla-Dave A, Poptani H, Loevner LA, Mancuso A, Serrai H, Rosenthal DI, Kilger AM, Nelson DS, Zakian KL, Arias-Mendoza F, Rijpkema M, Koutcher JA, Brown TR, Heerschap A, Glickson JD. Prediction of treatment response of head and neck cancers with P-31 MR spectroscopy from pretreatment relative phosphomonoester levels. Acad Radiol. 2002 Jun; 9(6):688-94.
-
Drake RR, McMasters R, Krisa S, Hume SD, Rechtin TM, Saylors RL, Chiang Y, Govindarajan R, Munshi NC. Metabolism and activities of 3'-azido-2',3'-dideoxythymidine and 2',3'-didehydro-2',3'-dideoxythymidine in herpesvirus thymidine kinase transduced T-lymphocytes. Antiviral Res. 1997 Aug; 35(3):177-85.
-
Thiers B. Herpes-varicella-zoster. J Am Acad Dermatol. 1980 May; 2(5):443-7.
-
Notari RE. Pharmacokinetics and molecular modification: implications in drug design and evaluation. J Pharm Sci. 1973 Jun; 62(6):865-81.
-
Notari RE, Witiak DT, DeYoung JL, Lin AJ. Comparative kinetics of cytosine nucleosides. Influence of a 6-methyl substituent on degradation rates and pathways in aqueous buffers. J Med Chem. 1972 Dec; 15(12):1207-14.
-
Notari RE, Chin ML, Cardoni A. Intermolecular and intramolecular catalysis in deamination of cytosine nucleosides. J Pharm Sci. 1970 Jan; 59(1):27-32.
-
Molinoff PB, Landsberg L, Axelrod J. An enzymatic assay for octopamine and other beta-hydroxylated phenylethylamines. J Pharmacol Exp Ther. 1969 Dec; 170(2):253-61.